Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Stocks Shoot Up 45% But Its P/S Still Looks Reasonable

Simply Wall StFeb 7 07:09 ET

Express News | Eton Pharmaceuticals Announced That United States Patent And Trademark Office Has Granted U.S. Patent No. 12,214,010, Covering Its ET-600 Product Candidate's Proprietary Formulation Of Desmopressin Oral Solution; Patent Expires In 2044

BenzingaFeb 7 06:53 ET

Eton Pharmaceuticals Says ET-400 FDA Decision Delayed to May

MT NewswiresFeb 6 10:14 ET

Express News | Eton Pharmaceuticals: Do Not Expect Standard Extension to Significantly Affect Internal 2025 Rev Projections

ReutersFeb 6 06:50 ET

Express News | Eton Pharmaceuticals Announces Extension of Pdufa Goal Date for Et-400

ReutersFeb 6 06:50 ET

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

Eton PharmaceuticalFeb 6 00:00 ET